The association between mammographic density measures and aspirin or other NSAID use

Breast Cancer Research and Treatment

Volumn 132, Issue 1, 2012, Pages 259-266

  Stone, Jennifer ^a   Willenberg, Lisa ^b   Apicella, Carmel ^a   Treloar, Susan ^c   Hopper, John ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aspirin; Breast cancer; Mammographic density; NSAIDs; Risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTHRITIS; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENSITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; PAIN; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING; TREATMENT DURATION; TWINS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; RISK FACTORS;

EID: 84857913459     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1834-2     Document Type: Article

References (19)

1. Mangiapane S, Blettner M, Schlattmann P (2008) Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 17(2):115-124 (Pubitemid 351308510)
2. Takkouche B, Regueira-Mendez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a metaanalysis. J Natl Cancer Inst 100(20):1439-1447
3. Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, Zhang WC, Li X (2009) Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Res Treat 117(1):141-150
4. Agrawal A, Fentiman IS (2008) NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 62(3):444-449 (Pubitemid 351197419)
5. Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7(2):203-205 (Pubitemid 26068056)
6. McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159-1169
7. Boyd N, Martin L, Chavez S, Gunasekara A, Salleh A, Melnichouk O, Yaffe M, Friedenreich C, Minkin S, Bronskill M (2009) Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol. 10(6):569-580
8. Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J (2000) Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9(9):911-915
9. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9(9):917-921
10. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96(8):621-628 (Pubitemid 38584986)
11. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95(1):30-37 (Pubitemid 36124293)
12. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886-894
13. Odefrey F, Stone J, Gurrin LC, Byrnes GB, Apicella C, Dite G, Cawson J, Giles GG, Treloar SA, English DR, Hopper JL, Southey MC (2010) Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res 70(4):1449-1458
14. Treloar S, Hadfield R, Montgomery G, Lambert A, Wicks J, Barlow DH, O'Connor DT, Kennedy S (2002) The International Endogene Study: a collection of families for genetic research in endometriosis. Fertil Steril 78(4):679-685
15. Maskarinec G, Urano Y, Gill J, Kolonel LN (2008) Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density. Breast Cancer Res Treat 112(1):133-139
16. McTiernan A, Wang CY, Sorensen B, Xiao L, Buist DS, Aiello Bowles EJ, White E, Rossing MA, Potter J, Urban N (2009) No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Prev 18(5):1524-1530
17. Terry MB, Buist DS, Trentham-Dietz A, James-Todd TM, Liao Y (2008) Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(5):1088-1095
18. Teter B, Fuhrman B, Barba M, Muti P (2006) Aspirin use and mammographic density as a marker of breast cancer risk in postmenopausal women, in AACR Meeting Abstracts
19. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002) A longitudinal study of the effects of menopause on mammographic features. Cancer EpidemiolBiomarkers Prev 11(10 Pt 1):1048-1053 (Pubitemid 35192656)